Summary
Introduction

Multiple sclerosis is an immune-mediated inflammatory
This impairment of HPA response to stress in patients with rheumatoid arthritis is particularly interesting since it parallels demyelinating disease of uncertain aetiology. During the time of active demyelination in the rat model of experimental findings in experimental animals in both EAE and in arthritis. Mason et al. (1990) found a lower HPA response to stress allergic encephalomyelitis (EAE), there is activation of the hypothalamo-pituitary-adrenal (HPA) axis which is vital for in the Lewis rat than in the Piebald Viral Glaxo rat and went on to show that not only was the Lewis rat more susceptible recovery from the disease (MacPhee et al., 1989) . HPA activity has also been found to be increased in other to EAE, but if EAE-resistant Piebald Viral Glaxo rats were adrenalectomized and given corticosterone replacement that inflammatory diseases and may indeed act as a protective mechanism against an excessive immune response. In rats mimicked the levels in the Lewis rat, they developed EAE like Lewis rats. EAE in Lewis rats can be suppressed by with adjuvant-induced arthritis the HPA axis is chronically activated and diurnal rhythms of corticotropin (ACTH) and exogenously administered glucocorticoid and exacerbated by the potent anti-glucocorticoid RU38486 (Bolton and Flower, corticosterone are lost (Sarlis et al., 1992) . Patients with rheumatoid arthritis also have an activated HPA axis (Neeck 1989) . Sternberg et al. (1989a) also showed a susceptibility to arthritis and a reduced response to both inflammation and et al., 1990) with an impaired cortisol rhythm and a poor response to stress (Neeck et al., 1990; Chikanza et al., 1992) . stress in the Lewis rat. Furthermore, these rats had a reduced hypothalamic activation of corticotropin-releasing hormone and the NMR Research Unit, Institute of Neurology, London.
Patients who had hormone-profile studies were investigated (CRH) messenger ribonucleic acid (Sternberg et al., 1989b) and secretion of CRH (Calogero et al., 1992) in response to as inpatients and recruited during their hospital stay for diagnosis and treatment; others were investigated as instress when compared with the arthritis-resistant Fischer rat. This HPA hyporesponsiveness in Lewis rats appears to be patients or out-patients. Normal control subjects were recruited from the hospital staff and their friends and were associated with a generalized susceptibility to inflammatory diseases (Karalis et al., 1995) . studied as outpatients. Multiple sclerosis patients are subdivided into three subgroups: (i) relapsing-remitting These data raise the possibility that HPA hyporesponsiveness in man might also play a role in increasing susceptibility multiple sclerosis, (ii) secondary progressive multiple sclerosis and (iii) primary progressive multiple sclerosis to inflammatory disease. There is already some evidence that this might be the case in rheumatoid arthritis (Chikanza et al., (Thompson et al., 1991) . Most patients were in clinical relapse (within four weeks). The characteristics of the subjects 1992) and it is clearly important to assess whether this might also be the case for multiple sclerosis. Previous studies on are detailed below. Contra-indications to inclusion were the presence of major depressive illness, anxiety neurosis, current the hormonal status in limited numbers of patients with multiple sclerosis have produced fragmentary and conflicting sepsis, major cognitive impairment, epilepsy, pituitary adenoma, hypophysectomy and other inflammatory diseases. results (Wender and Gutowski, 1959; Teasdale et al., 1967; Millac et al., 1969; Klapps et al., 1992) . Data from a small
No patient under study was on current steroid or other immunomodulatory therapy. The study had prior approval series of multiple sclerosis patients has implicated a selective central impairment of the HPA axis (Michelson et al., 1994) by the National Hospital's medical ethics committee and the subjects' informed and signed consent. and other studies have shown variable adrenal sensitivity to ACTH (Fog, 1951; Alexander et al., 1971; Snyder et al., 1981) . Insulin-induced hypoglycaemia has been used with variable results (Teasdale et al., 1967; Millac et al., 1969) , Hormone-study protocols but this is an extremely potent non-specific stimulus with Blood was sampled via an i.v. indwelling Venflon catheter little chance of showing subtle differences between the into Vacutainer tubes. All samples were stored at Ϫ20°C multiple sclerosis subgroups. Other hormones may also be until analysis. involved in multiple sclerosis. Thus prolactin, which has been implicated as an immunomodulatory hormone (Jara et al., 1991) , has been found to be raised (Grinsted et al., Basal hormone and C-reactive protein (CRP) 1989; Kira et al., 1991) or normal concentrations and the hypothalamo-pituitary-gonadal (HPG) axis which Basal serum free T 3 , free T 4 , thyroid-stimulating hormone has long been known to be suppressed during stress (Selye, (TSH) , testosterone (males), oestradiol (females), luteinizing 1936) also deserves attention. The only way to clarify hormone (LH), follicle-stimulating hormone (FSH) and the neuroendocrine consequences or possible aetiological plasma CRP were determined from morning samples taken relevance in multiple sclerosis was to carry out a full between 08.00 and 09.30 hours. prospective study in an adequate number of multiple sclerosis patients. Since there may be different aetiological factors (Olerup et al., 1989) and inflammatory activity (Thompson Baseline cortisol and prolactin profiles et al., 1991; Revesz et al., 1994) in different subgroups of Samples of blood were taken throughout the day (06.30, patients this must also be taken into account in classifying then 2-hourly 08.00-24.00 and, in addition, half-hourly the patients into appropriate diagnostic classes and in 08.00-10.00 and 20.00-22.00) for serum cortisol and correlating with indices of inflammatory disease activity. We prolactin measurements. now report our findings in 52 patients together with those in healthy controls and patients with other neurological disorders.
Stimulation and suppression tests
Human CRH (CRH Ferring, Kiel, Germany) was injected i.v. (100 µg over 1 min) in the morning (Oppermann, Methods 1986), blood was taken at 20-min intervals for 60 min. The combined thyrotropin-releasing hormone (TRH),
Patients
Fifty-two patients with clinically definite multiple sclerosis gonadotropin-releasing hormone (GnRH) and synthetic ACTH tests (Hall et al., 1980) followed the CRH test. (Poser et al., 1983) in-house radioimmunoassay (Jessop et al., 1994) . The ACTH antiserum did not recognize β-END and the β-END antiserum See footnote of Table 2 for abbreviations.
did not cross-react with ACTH. Serum testosterone was measured by in-house radioimmunoassay. Other serum used to investigate aspects of hormonal data with one another hormones were assayed using enzyme-linked immunosorbant and the log e of CRP concentrations. P Ͻ 0.05 was regarded assay in an automated analyser. Concentrations of CRP in as statistically significant. plasma of Ͻ2 mg/l was measured by an in-house enzymelinked immunosorbant assay and CRP Ͼ2 mg/l by a commercial radial immunodiffusion assay (Giovannoni et al., 1996) .
Results
Between-batch coefficients of variation were: ACTH and β-END, Ͻ15%; cortisol 3.7%; prolactin 8.8%; free T 4 2.5%;
Basal thyroid hormones
Data were obtained from 52 multiple sclerosis patients in four free T 3 3.5%; TSH 3.4%; LH 6.5%; FSH 6.6%; oestradiol 12.5%; testosterone 7.8% and CRP 7.9%.
groups (relapsing-remitting multiple sclerosis : secondary progressive multiple sclerosis : primary progressive multiple sclerosis ϭ 19 : 21 : 12), also from five patients with other neurological diseases and 10 normal control subjects. The
MRI
Brain images were obtained in a 1.5 Tesla superconducting mean ages (range) in these five groups were 39.8 (25-68), 43.2 (24-70), 46.4 (32-57), 42.4 (19-60) and 33.1 (24-53) system (General Electric, Milwaukee, USA). Duo-echo T 2 -weighted (TR 3500 , TE ef90/100 ) and proton density-weighted years, respectively. There were no significant differences between the groups for free T 3 , free T 4 or TSH (data (TR 2900 , TE ef18/20 ) axial brain fast spin echo images were obtained using head coil before gadolinium (Thorpe et al., not shown). 1994) and T 1 -weighted spin echo images (TR 640 , TE 14 ) after gadolinium (5-mm thick, contiguous slices, 256ϫ256 matrix and one excitation). Gadolinium (Magnevist ® , Schering,
Basal testosterone, LH and FSH in males
Data for testosterone, LH and FSH were obtained from Burgess Hill, UK) was given at 0.1 mmol/kg as an i.v. bolus. 25 male multiple sclerosis patients (relapsing-remitting multiple sclerosis : secondary progressive multiple sclerosis : primary progressive multiple sclerosis ϭ 7 : 10 : 8) and
Curve-fitting method
For cortisol profiles, data were fitted to cosine curves six normal control subjects. Their mean ages (range) were 36.6 (25-49), 40.4 (29-56), 44.9 (32-57) and 34.7 (26-53) (Nelson et al., 1979) . The general equation for the curve is:
years, respectively. There was no significant difference in the mean testosterone concentrations between groups (data concentration at time t, C 0 is the mesor mean, C is the amplitude, ω is the angular frequency, φ is the acrophase. not shown). Of all 25 of the male multiple sclerosis patients, six (24.0%, mean age 37.8 years, range: 32-48 years) had Constraints were: C ഛ C 0 ; 40 ഛ φ ഛ 135; 0 ഛ C 0 ; ωt ϭ 360; 10 ഛ ω ഛ 15 and (φ/9) ഛ ω ഛ (φ/4). serum testosterone below the lower limit of normal (Table  1) and did not have appropriately elevated LH or FSH.
Statistics
Data are presented as the mean (Ϯ SE) and hormone
Basal oestradiol, LH and FSH in females
Data for oestradiol were available in 26 female multiple concentrations were rounded to one decimal place unless otherwise stated. Time-integrated hormone responses were sclerosis patients (relapsing-remitting multiple sclerosis : secondary progressive multiple sclerosis : primary progressive calculated as the area under curve by integration of fitted curves (cortisol profiles) or a trapezium method. CRP data multiple sclerosis ϭ 14 : 9 : 3) and 4 normal control subjects. Their mean ages (range) were 41.0 (25-68), 45.7 (24-70), were analysed a log e transformation. Data were compared by Student's t test or single-factor analysis of variance, as 47.3 (35-51) and 30.8 (24-51) years, respectively. Four out of 16 (25%) pre-menopausal patients had low oestradiol appropriate. Statistically significant data were examined post hoc by the Newman-Keuls test. Correlation analysis was concentrations (Ͻ 100 pmol/l). Six patients were post- menopausal and not on hormone replacement therapy; all under the curve were not significantly different between groups (data not shown). The basal β-END concentrations had low oestradiol concentrations consistent with postmenopausal status. Five of them had normal post-menopausal were not significantly different between groups (Table 3) . The mean total area under the curve for β-END was levels of LH and FSH but one patient with relapsingremitting multiple sclerosis had an inappropriately low serum significantly different between groups (P ϭ 0.015, Fig. 2B ); in the relapsing-remitting multiple sclerosis group it was FSH of 12.7 U/l.
significantly greater than that in the primary progressive multiple sclerosis group (P Ͻ 0.05), secondary progressive multiple sclerosis (P Ͻ 0.01) and normal control (P Ͻ
Cortisol profiles
Details of patient groups are summarized in Table 2 . The 0.05) groups. mean profile characteristics of cortisol are shown in Fig. 1A . Although there were individual variations in the shape of the curves, a diurnal rhythm was present in each case.
TRH test
The mean area under the curve for the whole profile period There were no significant differences in the TSH and prolactin did not differ between the groups. The mean cortisol curve responses between groups (see group details in Table 4 ; data amplitude (ϮSE) was just significantly different between otherwise not shown). groups (relapsing-remitting multiple sclerosis, 163.7 Ϯ 13.5; secondary progressive multiple sclerosis, 141.8 Ϯ 7.6; primary progressive multiple sclerosis, 124.1 Ϯ 6.7; other Synthetic ACTH test neurological diseases, 184.6 Ϯ 18.8 nmol/l, P ϭ 0.048), but
All the patients and control subjects (Table 4) had final serum on post hoc testing there was only a trend for the mean cortisol concentrations of Ͼ550 nmol/l. There was a trend cortisol curve amplitude from both primary progressive for a difference in the mean baseline cortisol concentrations: multiple sclerosis and secondary progressive multiple which were the lowest in the relapsing-remitting multiple sclerosis groups to be significantly lower than that in the sclerosis group (P ϭ 0.07). The mean total and the net group with other neurological diseases (P Ͻ 0.06, P Ͻ 0.07, increase in area under the curve did not differ between groups respectively). (Fig. 2C) .
Prolactin profiles GnRH test
The mean total area under the prolactin curve did not differ Only two male multiple sclerosis patients (both relapsingsignificantly between groups (Fig. 1B) .
remitting multiple sclerosis) responded abnormally: one patient had a delayed but adequate response; another patient had an exaggerated response to GnRH (Mortimer, 1977) . All
CRH test
except one of 15 female patients responded normally. The patterns of cortisol responses were similar in the patient and normal control groups (Table 3 ). The mean total area under the curve of cortisol over 60 min differed significantly between groups (P ϭ 0.016; Fig. 2A) , with that of the
Dexamethasone-suppression test
This was performed in 10 multiple sclerosis patients secondary progressive multiple sclerosis being significantly lower than those of the primary progressive multiple sclerosis (relapsing-remitting multiple sclerosis : secondary progressive multiple sclerosis : primary progressive multiple and normal control groups (P Ͻ 0.05 in both, Table 3 ). Data were available for ACTH in multiple sclerosis patients only; sclerosis ϭ 2 : 6 : 2). All patients had cortisol suppression post-dexamethasone. Seven patients had MRI with gadolinthe mean basal ACTH concentrations and the total areas Table 2 footnote. These are actual data, not fitted curves.
ium but had only two enhanced T 1 lesions: they both had Ϯ 613.8 pg·min/ml) was significantly greater than those who did not (7184.6 Ϯ 538.7 pg·min/ml, P Ͻ 0.001). The mean undetectable post-dexamethasone cortisol.
total area under the curve for the cortisol response to synthetic ACTH in patients who enhanced was significantly lower
Correlations between CRP and hormonal data Correlation between hormone data and fatigue was negatively correlated with the net increase in area No significant difference in hormone measures was found under the curve in the cortisol response to CRH [r(21) ϭ between patients with and without fatigue (data not shown). Ϫ0.48, P Ͻ 0.03, Fig. 3B ].
Correlations between MRI and hormone data in Discussion
This study was designed to provide definitive evidence for multiple sclerosis patients any change (or lack of change) in neuroendocrine activity in The mean total area under the curve of the ACTH response to CRH in multiple sclerosis patients who enhanced (11092 well-defined subgroups of patients with multiple sclerosis, Age and EDSS are given as mean (and range), rounded to the nearest integer and by one decimal place, respectively. AUC ϭ area under the curve; NC ϭ normal control subjects. For all other abbreviations see Table 2 footnote. 1 P ϭ 0.016 between groups; 2 P Ͻ 0.05 comparing 2PMS with 1PMS and NC groups; 3 P ϭ 0.015 between groups; 4 P Ͻ 0.01, RRMS versus 2PMS group; 5 P Ͻ 0.05, RRMS versus 1PMS and NC groups. Table 2 footnote. 3.5 (1-6.5) 6.6 (3-9) 6.5 (3.5-8) NA Males : females 4 : 6 5 : 6 3 : 3 5 : 4 Gd-MRI (enhanced) 7 (3) 6 (3) 6 (0) NA Fatigue 2 2 1 NA NC ϭ normal control subjects. For all other abbreviations see Table 2 footnote. Age and EDSS are given as mean (and range), rounded to the nearest integer and by one decimal place, respectively.
Fig. 3
Relationships between (A) mesor mean cortisol level (Co) in cortisol profiles, and (B) cortisol response (net increase in AUC) in the CRH test, and C-reactive protein (ln CRP) in multiple sclerosis patients. A regression line is shown in each. The upper limit of the normal concentration of CRP is 2.08 ng/ml (ln 2.08 ϭ 0.73).
with additional information from gadolinium enhanced MRI (Giovannoni et al., 1996; Rovaris et al., 1996) . Acute EAE is associated with a marked degree of non-specific stress scans and CRP. In particular, we sought to discover whether there was any evidence for altered HPA activity, as has been (Levine et al., 1980) . The magnitude of HPA activation in our patients is comparable to patients with rheumatoid demonstrated in EAE susceptible rats.
Diurnal cortisol rhythms and time-integrated cortisol proarthritis (Neeck et al., 1990) and those with non-inflammatory arthropathy having major surgery (Chikanza, et al., 1992) . duction were preserved in patients with multiple sclerosis. Correlation of rhythm parameters with CRP, which is a
The magnitude of HPA activation was in agreement with post-mortem immunocytochemical data, which revealed upmarker for the acute phase of the systemic response and which is modestly raised during relapses of multiple sclerosis, regulation of immunoreactive-CRH neurons (Erkut et al., 1995; Purba et al., 1995) . In contrast, this was not found in infection and MRI activity (Giovannoni et al., 1996) , reveals upregulation of the HPA axis in response to stressors in patients with other diseases (Erkut et al., 1995) and argues against non-specific HPA activation during illness in general. multiple sclerosis. A possible common mediator in upregulating CRP and the HPA axis is interleukin-6, which These CRH neurons co-expressed arginine vasopressin, which has been implicated in the study of Michelson et al. (1994) is elevated in multiple sclerosis (Frei et al., 1991; Rovaris et al., 1996) . In rheumatoid arthritis patients, the cortisol but its precise role remains uncertain. Multiple sclerosis patients who showed gadolinium response to CRH has also been shown to correlate with changes in CRP levels (Gudbjörnsson et al., 1996) . The enhancement on MRI, which serves as another index of inflammation (Katz et al., 1993) , had a significantly higher extent of activation of the HPA axis in multiple sclerosis patients (Fig. 3A) is up to 2.5-fold that in normal controls, ACTH response to CRH, but a significantly lower cortisol response to synthetic ACTH than those who did not. The which is modest in contrast to the six-fold increase in EAE. This appears at first surprising. However, many patients did total time-integrated hormonal responses correlated with basal concentrations (data not shown). Therefore, the HPA not have gandolinium enhancement on MRI and their CRP levels were mostly normal or slightly elevated. Detection of axis is centrally upregulated in the presence of active inflammation. Despite this, these patients had low cortisol inflammatory mediators in the CNS or the periphery in multiple sclerosis has been inconsistent; they have been response at the adrenal level; this implies a state of reduced adrenal reserve or adrenal insensitivity. Adrenal hypofound to be transiently expressed or expressed at low levels responsiveness has also been found in patients with hypothalamo-pituitary-thyroid (HPT) and HPG axes in our patients were intact; only a minority had low testosterone/ rheumatoid arthritis (Gudbjörnsson et al., 1996) and fatigue oestradiol and an even smaller number had a delayed syndromes (Sternberg, 1993) . The possible mechanisms have gonadotropin response to GnRH. Although the HPG axis can been discussed by Grasser et al. (1996) who found some be suppressed by HPA activation, cytokines and chronic multiple sclerosis adrenals were hyporesponsive while most illness, these would not adequately explain the hypogonadowere hyperresponsive. Adrenal size was unknown in our trophic hypogonadism in these isolated patients. As the patients but in a post-mortem study was found to be increased GnRH test was normal in the vast majority, a hypothalamic (Reder et al., 1994) , consistent with chronic hypersecretion rather than pituitary defect was likely; a small part of of ACTH, which would be expected to result in increased the hypothalamus might have been selectively affected by adrenal reserve. The adrenal response to ACTH during multiple sclerosis plaque formation resulting in altered therapy has been shown to be variable in multiple sclerosis GnRH release. (Fog, 1951; Alexander et al., 1971; Snyder et al., 1981) . Thus,
In assessing how closely our data on the HPA axis agree the evidence indicates a spectrum of adrenal responsiveness in with those in EAE, the relationship between multiple sclerosis multiple sclerosis .
and EAE must be borne in mind. In EAE, the hormonal The increased β-END response to CRH in the relapsingmeasurements were made during the first attack (MacPhee remitting multiple sclerosis group suggested central upet al., 1989) , but have not been repeated in animals with regulation of CRH neurons although this was mainly due to chronic relapsing EAE, which arguably resembles the disease three patients with huge responses: the apparent discrepancy course and process in multiple sclerosis more closely than with measured ACTH response may partly be due to their acute EAE. Here, the patients were studied subsequent to different plasma half-lives. The negative correlation between their first demyelinating episode. Nonetheless, activation of the log e ([CRP]) and the incremental cortisol response (the the HPA axis is found in both multiple sclerosis and EAE. net increase in area under the curve) to CRH also implies Activation of the HPA axis in multiple sclerosis relapses is that basal HPA activity is upregulated, since we found that potentially important for subsequent recovery, according to the net increase in area under the curve negatively correlated the known anti-inflammatory actions of steroids. The Lewis with the basal pre-stimulatory cortisol concentrations (data rat model of generally increased susceptibility to inflammanot shown).
tory diseases is remarkable but probably an extreme model, The mean total time-integrated cortisol response to CRH as these inbred rats have an HPA response at the lower range in the secondary progressive multiple sclerosis group was of normal of that of outbred Sprague-Dawley rats (Karalis significantly lower than those of the primary progressive et al., 1995) . More importantly, although a robust HPA multiple sclerosis and normal control groups: the former also response is crucial for recovery from EAE, it is clearly not tended to have the lowest mean basal pre-stimulatory cortisol responsible for the subsequent refractory state (MacPhee concentrations. In contrast, patients with active rheumatoid et al., 1989). arthritis had normal cortisol response to ovine CRH but all
The role of the HPA axis in the initial pathogenesis of of them were on treatment (Chikanza et al., 1992) . Thus, multiple sclerosis appears at best to be minor. The Lewis rat there is reduction in the cumulative HPA response to stress is susceptible to EAE because of consistently impaired HPA in secondary progressive multiple sclerosis patients, but the response to stress. Most multiple sclerosis patients have a degree of impairment is less than that in rodent models normal stress response. We have argued that the modest (Sternberg et al., 1989a; Mason et al., 1990) . This is likely degree of HPA activation in multiple sclerosis is not to be a consequence of the disease, or related to altered HPA necessarily inappropriate. Some rat strains are resistant to axis regulation from chronic activation. This group of patients EAE even if adrenalectomized (Mason et al., 1990) . Clearly, might have had more courses of steroid therapy in the distant non-hormonal factors are implicated. The hypothesis that past, but any suppression of the HPA axis recovers rapidly hyporesponsiveness of the HPA axis in humans predisposes (Wenning et al., 1994) .
to multiple sclerosis cannot, at present, be directly tested Our data might have been confounded by the presence of before disease develops. Nonetheless, by analogy to animal fatigue or depression in multiple sclerosis patients. Fatigue models, the finding of intact HPA function in most of our syndromes have been reported to be associated with hypopatients implies that HPA impairment is unlikely to make a responsiveness of the HPA axis (Sternberg, 1993) . We had substantial contribution to its initial pathogenesis. Also, the not primarily set out to study this and the number of patients normal HPA responses in most patients do not support an with fatigue was small. Our patients were not clinically important role for HPA impairment in disease perpetuation depressed although no formal psychiatric evaluation was or progression in general, but it may be a contributory factor in carried out and alterations of the HPA activity in multiple a small proportion of patients with hyporesponsive adrenals. sclerosis are thought not to be due to depression (Michelson et al., 1994) .
Our patients had intact feedback regulation, in contrast
